RT Conference Proceedings
T1 A Phase IIB Trial of Docetaxel Concurrent with Radiation Therapy Plus Hormonotherapy Versus Radio Hormonotherapy in High-Risk Localized Prostate Cancer: Late Toxicity Analysis
A1 Foro, P.
A1 Maldonado, J.
A1 Bonet, M.
A1 Jove-Teixido, J.
A1 Rovirosa, A.
A1 Sancho Pardo, G.
A1 Mira Flores, M.
A1 Bejar Luque, A.
A1 Carles, J.
PB Elsevier science inc
SN 0360-3016
YR 2018
FD 2018-11-01
LK https://hdl.handle.net/10668/25357
UL https://hdl.handle.net/10668/25357
LA en
DS RISalud
RD Apr 17, 2025